These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12943483)

  • 1. Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease.
    Rosendorff C
    Expert Opin Pharmacother; 2003 Sep; 4(9):1535-41. PubMed ID: 12943483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the hypertensive patient with ischemic heart disease.
    Rosendorff C
    Curr Hypertens Rep; 2002 Oct; 4(5):350-7. PubMed ID: 12217252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of elderly patients with hypertension--complications and current drug therapy].
    Takagawa Y; Shimamoto K; Masuda A; Iimura O
    Nihon Ronen Igakkai Zasshi; 1997 Jan; 34(1):30-7. PubMed ID: 9077102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B
    Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
    Moser M
    Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
    Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
    Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination drug therapy with calcium-channel blockers in the treatment of systemic hypertension.
    Frishman WH; Landau A; Cretkovic A
    J Clin Pharmacol; 1993 Aug; 33(8):752-5. PubMed ID: 8104960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
    Bath P
    Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive therapy. Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and calcium antagonists.
    Gifford RW
    Med Clin North Am; 1997 Nov; 81(6):1319-33. PubMed ID: 9356601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
    Aronow WS
    Expert Opin Pharmacother; 2016; 17(2):205-15. PubMed ID: 26373919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists or beta-blockers in chronic ischaemic left ventricular dysfunction?
    Pouleur H
    Eur Heart J; 1993 Oct; 14 Suppl F():26-8. PubMed ID: 7903245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.